1
Dec, 2020
Celebrating #WorldAidsDay – Gianni’s ‘Looking for Lydia’ Documentary
Gianni Ferraretto, an Italian filmmaker, visited Kampala, Uganda three times between 2009 and 2019 to uncover the story of young people living with HIV.
News
19
Nov, 2020
WHO Essential Medicines List (EML) New Antibiotic User Guide
On November 23rd, 2020, the World Health Organisation will be hosting a webinar on the Essential Medicines List (EML) new Antibiotic User Guide.
19
Nov, 2020
European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
On November 12th, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending marketing authorisation for dolutegravir 5mg dispersible tablets for young children living with HIV. This decision was based, in part, on data from the ODYSSEY trial. These small tablets can now be used in combination with other medicines for treating children living with HIV who are aged at least four weeks and weigh at least 3kg. CHMP’s positive opinion also supported the updated dosing recommendations for dolutegravir film-coated […]
19
Nov, 2020
#WorldAntimicrobialAwarenessWeek: Antimicrobial Stewardship Programs (ASPs)
In the spirit of World Antimicrobial Awareness Week, we’d like to share a summary of the findings from the “Implementation and Impact of Paediatric Antimicrobial Stewardship Programs: A Systematic Scoping Review” study. As you may already know, Antimicrobial Stewardship Programs (ASPs) are a set of coordinated interventions designed to improve the selection of the appropriate agent, dose, route of administration, and therapy duration without compromising patient outcomes.
10
Nov, 2020
Irja Lutsar has been elected as Estonia’s Woman of the Year
Professor Irja Lutsar, a prominent and active member of the Penta network for many years, has been elected as Estonia’s Woman of the Year by the Business and Professional Women Organisation (BPW), Estonia.
10
Nov, 2020
Louise Hill Presents NeoVanc Sub-study Results at ESPID 2020
Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings. Enterococcus (a bacterium) and candida (a fungus) can sometimes be found on or in the human body. Occasionally enterococci can develop resistance to one of the antibiotics usually used to treat it – vancomycin. Vancomycin use has been linked to a rise in vancomycin-resistant enterococci and candida on or in the bodies of babies admitted to the neonatal intensive care unit. Babies with vancomycin-resistant […]
5
Nov, 2020
RESCEU: Fighting Respiratory Syncytial Virus and its economic impact
Europe’s project RESCEU sheds new light on the fight against the Respiratory Syncytial Virus (RSV) and its economic impact
2
Nov, 2020
PentaTr@ining 2020 online training course kicks off!
Our completely revamped online training course PentaTr@ining 2020: ‘HIV & other Congenital Infections’ kicks off today!
26
Oct, 2020
Launch of Global Accelerator for Paediatric Formulations (GAP-f) by WHO
Penta is the lead of the Clinical Research Working Group for the newly launched Global Accelerator for Paediatric Formulations (GAP-f), a network led by the World Health Organisation.
16
Oct, 2020
c4c publishes first peer reviewed publication
The c4c project, co-coordinated by Penta together with Janssen, Bayer and the University of Liverpool, has had its first review, titled “European research networks to facilitate drug research in children”, published by the British Journal of Clinical Pharmacology. We are proud to have the Penta_ID Network involved in such an impactful project as a speciality network. This review discusses the need for a structured approach to drug development by establishing and utilizing research networks and infrastructure. The publication explores how research networks and infrastructure can address the unmet medical […]
